Cargando…
Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol
LAT1 (SLC7A5) is a transporter for both the uptake of large neutral amino acids and a number of pharmaceutical drugs. It is expressed in numerous cell types including T-cells, cancer cells and brain endothelial cells. However, mechanistic knowledge of how it functions and its interactions with lipid...
Autores principales: | Dickens, David, Chiduza, George N., Wright, Gareth S. A., Pirmohamed, Munir, Antonyuk, Svetlana V., Hasnain, S. Samar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341093/ https://www.ncbi.nlm.nih.gov/pubmed/28272458 http://dx.doi.org/10.1038/srep43580 |
Ejemplares similares
-
LAT1 (SLC7A5) and CD98hc (SLC3A2) complex dynamics revealed by single-particle cryo-EM
por: Chiduza, George N., et al.
Publicado: (2019) -
ATP modulates SLC7A5 (LAT1) synergistically with cholesterol
por: Cosco, Jessica, et al.
Publicado: (2020) -
A faulty interaction between SOD1 and hCCS in neurodegenerative disease
por: Wright, Gareth S. A., et al.
Publicado: (2016) -
Putative roles of SLC7A5 (LAT1) transporter in pain
por: Alles, Sascha R.A., et al.
Publicado: (2020) -
Ubiquitylation and endocytosis of the human LAT1/SLC7A5 amino acid transporter
por: Barthelemy, Céline, et al.
Publicado: (2019)